[Tyrosine kinase inhibitors as the targeted therapy for leukemia].
Heikinheimo
M
M
D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
D004791:Enzyme Inhibitors; D011505:Protein-Tyrosine Kinases